Reperio Health, Inc. — Form D

Reperio Health, Inc. of PORTLAND, OR, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-02. The offering totals $4.0M, of which $1.0M was reported sold. Industry: Other Technology.

Offering

Filed: 2024-07-02
Form: D
Accession: 0001826782-24-000002
Industry: Other Technology
Exemptions: 06b
Total offering: $4.0M
Amount sold: $1.0M
Remaining: $3.0M
Investors: 1
Date of first sale: 2024-05-23
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-517585

Issuer

Name: Reperio Health, Inc.
CIK: 0001826782
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2020
Address: 4784 SE 17TH AVE, SUITE 120, PORTLAND, OR, 97202
Phone: 503-522-8024

Officers, directors & promoters (10)

Name	Role	Location
Matthew Wallington	Director	Portland, OR
Matthew Wallington	Executive Officer	Portland, OR
Philip Hertik	Director	Portland, OR
Travis Rush	Director	Portland, OR
Travis Rush	Executive Officer	Portland, OR
JUSTIN AUTREY	Executive Officer	PORTLAND, OR
ELIZABETH CURTIS	Executive Officer	PORTLAND, OR
TORY ADAMS	Executive Officer	PORTLAND, OR
CHARLES JEWELL	Executive Officer	PORTLAND, OR
ILDIKO CRIST	Executive Officer	PORTLAND, OR

Other filings by this issuer (8)

Filed	Form	Offering	Sold
2024-12-27	D/A	$8.5M	$5.1M
2024-04-09	D	$2.0M	$1.6M
2023-11-09	D	$2.0M	$500K
2023-09-08	D/A	$8.2M	$8.2M
2023-05-23	D	$5.0M	$2.0M
2022-01-07	D	$5.0M	$1.6M
2021-03-17	D/A	$8.0M	$6.0M
2020-10-15	D	$8.0M	$2.8M

More